49 results on '"Sidiki S"'
Search Results
2. Mycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent manner
- Author
-
Arcos, J., Sasindran, S.J., Moliva, J.I., Scordo, J.M., Sidiki, S., Guo, H., Venigalla, P., Kelley, H.V., Lin, G., Diangelo, L., Silwani, S.N., Zhang, J., Turner, J., and Torrelles, J.B.
- Published
- 2017
- Full Text
- View/download PDF
3. The effect of socio-economic deprivation on severity of glaucoma at presentation
- Author
-
Ng, W S, Agarwal, P K, Sidiki, S, McKay, L, Townend, J, and Azuara-Blanco, A
- Published
- 2010
- Full Text
- View/download PDF
4. Tropical Waves Are Key Drivers of Extreme Precipitation Events in the Central Sahel
- Author
-
Philippe Peyrillé, Romain Roehrig, and Sidiki Sanogo
- Subjects
extreme precipitation ,tropical waves ,Sahel ,convectively coupled equatorial waves ,Geophysics. Cosmic physics ,QC801-809 - Abstract
Abstract Extreme precipitation events (EPE) are often associated with severe floods and significant damages in Central Sahel. To better understand their formation and improve their forecasts, we investigate the sub‐seasonal drivers of EPEs. A composite analysis reveals that moist, cyclonic and upper‐level divergence anomalies are found on average as a result of several tropical waves. The equatorial Rossby wave (ER) dominates at large scale providing a moist and convectively‐active anomaly over the northern Sahel together with a smaller‐scale African Easterly Wave (AEW). The Madden‐Julian Oscillation provides upper‐level divergence anomalies and a Kelvin wave increases convection during the EPE. Statistics show the prevalence of AEW and emphasize ER as a key driver of EPE. The co‐occurrences of several tropical waves, especially those involving AEW, ER, and Kelvin waves, increase the probability of EPE. Monitoring these tropical waves combinations could improve EPEs forecasts.
- Published
- 2023
- Full Text
- View/download PDF
5. Startup financing trends in Europe
- Author
-
Sidiki, S., Sidiki, S., Sidiki, S., and Sidiki, S.
- Published
- 2014
6. The human lung mucosa drives differential Mycobacterium tuberculosisinfection outcome in the alveolar epithelium
- Author
-
Scordo, J. M., Olmo-Fontánez, A. M., Kelley, H. V., Sidiki, S., Arcos, J., Akhter, A., Wewers, M. D., and Torrelles, J. B.
- Abstract
Mycobacterium tuberculosis(M.tb) is deposited into the alveolus where it first encounters the alveolar lining fluid (ALF) prior contacts host cells. We demonstrated that M.tb-exposure to human ALF alters its cell surface, driving better M.tbinfection control by professional phagocytes. Contrary to these findings, our results with non-professional phagocytes alveolar epithelial cells (ATs) define two distinct subsets of human ALFs; where M.tbexposure to Low (L)-ALF or High(H)-ALF results in low or high intracellular bacterial growth rates in ATs, respectively. H-ALF exposed-M.tbgrowth within ATs was independent of M.tb-uptake, M.tb-trafficking, and M.tb-infection induced cytotoxicity; however, it was associated with enhanced bacterial replication within LAMP-1+/ABCA1+compartments. H-ALF exposed-M.tbinfection of ATs decreased AT immune mediator production, decreased AT surface adhesion expression, and downregulated macrophage inflammatory responses. Composition analysis of H-ALF vs. L-ALF showed H-ALF with higher protein tyrosine nitration and less functional ALF-innate proteins important in M.tbpathogenesis. Replenishment of H-ALF with functional ALF-innate proteins reversed the H-ALF-M.tbgrowth rate to the levels observed for L-ALF-M.tb. These results indicate that dysfunctionality of innate proteins in the H-ALF phenotype promotes M.tbreplication within ATs, while limiting inflammation and phagocyte activation, thus potentiating ATs as a reservoir for M.tbreplication and survival.
- Published
- 2019
- Full Text
- View/download PDF
7. Fear of the dark in children: is stationary night blindness the cause?
- Author
-
Sidiki, S., Hamilton, R., and Dutton, Gordon N.
- Subjects
RJ101 - Abstract
No abstract available.
- Published
- 2003
8. Mycobacterium tuberculosiscell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent manner
- Author
-
Arcos, J., Sasindran, S.J., Moliva, J.I., Scordo, J.M., Sidiki, S., Guo, H., Venigalla, P., Kelley, H.V., Lin, G., Diangelo, L., Silwani, S.N., Zhang, J., Turner, J., and Torrelles, J.B.
- Abstract
Mycobacterium tuberculosis (M.tb), the causative agent of tuberculosis, is a major public health challenge facing the world. During infection, M.tbis deposited in the lung alveolar space where it comes in contact with the lung mucosa, known as alveolar lining fluid (ALF), an environment that M.tbencounters at different stages of the infection and disease. ALF is abundant in homeostatic and antimicrobial hydrolytic enzymes, also known as hydrolases. Here we demonstrate that ALF hydrolases, at their physiological concentrations and upon contact with M.tb,release M.tbcell envelope fragments into the milieu. These released fragments are bioactive, but non-cytotoxic, regulate the function of macrophages, and thus are capable of modulating the immune response contributing to the control of M.tbinfection by human macrophages. Specifically, macrophages exposed to fragments derived from the exposure of M.tbto ALF were able to control the infection primarily by increasing phagosome–lysosome fusion and acidification events. This enhanced control was found to be dependent on fragment-induced interleukin-10 (IL-10) production but also involves the STAT3 signaling pathway in an IL-10-independent manner. Collectively our data indicate that M.tbfragments released upon contact with lung mucosa hydrolases participate in the host immune response to M.tbinfection through innate immune modulation.
- Published
- 2017
- Full Text
- View/download PDF
9. The effect of socio-economic deprivation on severity of glaucoma at presentation
- Author
-
Ng, W S, primary, Agarwal, P K, additional, Sidiki, S, additional, McKay, L, additional, Townend, J, additional, and Azuara-Blanco, A, additional
- Published
- 2009
- Full Text
- View/download PDF
10. Use of disposable prism tonometry in routine clinical practice
- Author
-
Salvi, S M, primary, Sivakumar, S, additional, and Sidiki, S S, additional
- Published
- 2004
- Full Text
- View/download PDF
11. Lesson of the week: Fear of the dark in children: is stationary night blindness the cause?
- Author
-
Sidiki, S. S, primary
- Published
- 2003
- Full Text
- View/download PDF
12. Use of disposable prism tonometry in routine clinical practice.
- Author
-
Salvi, S. M., Sivakumar, S., and Sidiki, S. S.
- Subjects
EYE diseases ,TONOMETRY ,GLAUCOMA diagnosis ,INTRAOCULAR pressure ,MEDICAL care ,MEDICAL statistics - Abstract
Aim: To establish the reliability, efficacy, and safety of disposable prism tonometry and validate its routine use for screening as well as monitoring of glaucoma.Methodology: Intraocular pressure (IOP) of 400 eyes of 200 consecutive patients who attended the general ophthalmic clinic was checked with both the Goldmann applanation tonometer and a disposable tonometer prism by an experienced examiner after obtaining informed consent. The data were statistically analysed.Results: The mean difference in the IOP between the two types of prisms was 0.1 mmHg (SD+/-1 mmHg).Conclusion: Disposable prism tonometry provides a reliable, effective, and safe alternative to Goldmann reusable prism tonometry for routine screening as well as monitoring of glaucoma with the advantages of eliminating the need for chemical disinfection and therefore eliminating the risk of crossinfection. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
13. The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
- Author
-
Mindlen, F., Nordaby, R., Ruiz, M., Zavala, A., Guzman, L., Martinez, F., Diaz, Rr, Mackey, C., Marino, M., Romero, G., Zapata, G., Cuneo, C., Kawamura, T., Coelho, O., Massayochi, O., Braga, J., Labrunie, A., Bodanese, L., Manenti, E., Vitola, D., Nicolau, J., Amodeo, C., Armaganijan, D., Bertolami, M., Caramelli, B., Carvalho, A., Cirenza, C., Fichino, M., Franken, R., Ghorayeb, N., Kadri, T., Leao, P., Malheiros, F., Pavanello, R., Ramires, F., Ramires, J., Savioli, F., Sousa, A., Tanajura, L., Topps, D., Korner, L., Martinez, V., Baptie, B., Basinger, M., Baylis, B., Beresford, P., Edwards, A., Giannaccaro, P., Groenewoud, Y., Grose, M., Kellen, J., Lam, S., Lesoway, R., Ma, P., Meldrum, D., Mitchell, D., Mitchell, Lb, Roth, D., Shumak, S., Simon, M., Stone, J., Warnica, W., Wyse, D., Neffgen, C., Neffgen, J., Armstrong, F., Armstrong, W., Bell, N., Black, W., Brass, N., Brenneis, F., Brownoff, R., Chaytors, G., Debanne, D., Derksen, C., Donoff, M., Dzavik, V., Goeres, M., Greenwood, P., Gulamhusein, S., Hui, W., Hutchison, K., Kasian, L., Kasza, L., Krikke, E., Kvill, L., Lakhani, Z., Linklater, D., Mackel, J., Martin, S., Montague, T., Moores, D., Musseau, A., Muzyka, T., Paradis, J., Prosser, A., Ryan, E., Senaratne, M., Stenerson, P., Talibi, T., Teo, K., Young, C., Zuk, V., White, R., Browne, K., Browne, M., Happel, K., Irving, A., Plesko, A., Donnelly, R., Radomsky, N., Felker, P., Larsen, D., Morse, J., Rowntree, C., Thompson, J., Wedel, R., Bloomberg, G., Chomin, G., Dahl, M., Leong, W., Moy, V., Heath, J., Marshall, J., Terwiel, M., Kenefick, G., Kuritzky, R., Stevens, K., Weddings, K., Barban, K., Imrie, J., Woo, K., Ashton, T., Calvert, K., Bishop, W., Sweeney, R., Breakwell, L., Kornder, J., Pearce, S., Polasek, P., Richardson, P., Ghosh, S., Rielly, M., Wagner, K., Bemstein, V., Dawson, K., Lee, P., Lewis, J., Macdonald, K., Mcgee, L., Thompson, C., Hilton, D., Illott, K., Klinke, P., Mcconnell, J., Rabkin, S., Ong, A., Ong, G., Bedard, D., Hoeschen, R., Mehta, P., Mohammad, I., Morris, A., Bessoudo, R., Dobbins, N., Mclellan, L., Milton, J., Davis, R., Okeefe, D., Smith, R., Joyce, C., Parsons, M., Skanes, J., Sussex, B., Tobini, M., Ravalia, M., Sherman, G., Worrall, G., Atkinson, A., Hatheway, R., Johnson, B., Barnhill, S., Bata, I., Cosseet, J., Johnstone, D., Macfarlane, M., Sheridan, W., Crossman, L., Folkins, D., Shirley, M., Machel, T., Morash, J., Gupta, M., Mayich, M., Vakani, T., Baitz, T., Macphee, E., Turton, E., Turton, M., Chan, N., Misterski, J., Raco, D., Curnew, G., Fallen, E., Finkelstein, L., Gerstein, H., Hardman, P., Lawand, S., Lonn, E., Magi, W., Mcqueen, M., Panju, A., Patterson, R., Sullivan, B., Sullivan, H., Sullivan, M., Taylor, K., Worron, I., Yusuf, S., Cameron, W., Noseworthy, C., Houlden, R., Lavalle, T., Fowlis, R., Janzen, I., Arnold, M., Cann, M., Carroll, S., Dumaresq, S., Edmonds, M., Furlong, P., Geddes, C., Graham, E., Harris, K., Hramiak, I., Kennedy, R., Kostuk, W., Krupa, M., Lent, B., Lovell, M., Maclean, C., Massel, D., Mcmanus, R., Mcsherry, J., Munoz, C., Occhipinti, J., Oosterveld, L., Pflugfelder, P., Powers, S., Southern, R., Spence, D., Squires, P., Wetmore, S., Willing, J., Wisenberg, G., Wolfe, B., Kannampuzha, P., Rebane, T., Sluzar, V., Hess, A., Chan, Y., Thomson, D., Baigrie, R., Dubbin, J., Liuni, C., Tan, Kw, Brankston, E., Hewson, P., Hrycyshyn, B., Kapusta, W., Knox, L., Lockner, C., Whitsitt, P., Baird, M., Conroy, D., Davies, Ra, Davies, Rf, Fraser, M., Hagar, S., Hierlihy, P., Keely, E., Khan, S., Lau, Dgw, Marois, L., Nemeth, K., Reeves, E., Turek, M., Vexler, R., Young, D., Kumar, G., Kuruvilla, G., Kuruvilla, P., Lowe, D., Kwok, K., Blakely, J., Styling, S., Bozek, B., Charles, J., Fell, D., Fell, Da, Goode, E., Grossman, Ld, Matthews, E., Nitkin, R., Ricci, J., Selby, A., Singh, N., Swan, J., Emmett, J., Weingert, M., Ganjavi, F., Hill, D., Nawaz, S., Hessian, R., Kwiatkowski, K., Lai, C., Mulaisho, C., Okeefe, H., Smith, H., Weeks, A., Andrews, J., Barnie, A., Drobac, M., Hacker, P., Hanna, A., Iwanochko, M., Kenshole, A., Langer, A., Liu, P., Maclean, S., Moe, G., Sasson, Z., Sternberg, L., Trachuk, C., Walters, J., Zinman, B., Cheung, M., Cina, C., Yao, L., Man, K., Fulop, J., Glanz, A., Sibbick, M., Carter, P., Hickey, J., Mcmillian, E., Dion, D., Sthilaire, R., Coutu, D., Damours, G., Starra, R., Brooks, J., Dechamps, P., Kiwan, G., Kouz, S., Laforest, M., Remillard, C., Bellamy, D., Brossoit, R., Carrier, S., Houde, A., Labonte, I., Belanger, A., Kandalaft, N., Quenneville, L., Sandi, M., Auger, P., Bilodeau, N., Delage, F., Dumont, F., Giroux, R., Loisel, R., Poirier, C., Saulnier, D., Carmichael, P., Lemay, C., Lenis, J., Arisjilwan, N., Bedard, H., Casavant, C., Chiasson, J., Dagenais, D., Fitchett, D., Gossard, D., Halle, H., Hamel, N., Joyal, M., Magnan, O., Methe, M., Pedneault, L., Pilon, C., Poisson, D., Primeau, L., Rondeau, C., Roy, C., Ruel, M., Serpa, A., Sestier, F., Smilovitch, M., Theroux, P., Beaudoin, J., Boudreault, Jr, D Amours, D., Douville, T., Giguere, G., Houde, G., Labbe, R., Lachance, S., Lessard, L., Mercier, G., Noel, Hp, Talbot, P., Tremblay, J., Karabatsos, A., Maclellan, K., Wilson, P., Bogaty, P., Laforge, D., Langlais, M., Leblanc, M., Samson, M., Turcotte, J., Campeau, J., Dupuis, R., Lauzon, C., Ouimet, F., Pruneau, G., Desmaris, C., Frechetto, I., Gervais, P., James Brophy, Leroux, S., Bester, S., Meunier, L., Sayeed, M., Hart, M., Moumne, I., Thomasse, G., Walker, J., Walker, M., Ahmed, S., Habib, Nm, Kuny, P., Lopez, J., Klein, W., Grisold, M., Heyndrickx, L., Fiasse, A., Degaute, Jp, Mockel, J., Duprez, D., Chaudron, Jm, Bodson, A., Krzentowski, G., Boland, J., Kolendorf, K., Winther, B., Juhl, H., Hamalainen, T., Siitonen, O., Gin, H., Rigalleau, V., Hensen, J., Riel, R., Oehmenbritsch, R., Schulzeschleppinghoff, B., Hopf, R., Moller, A., Rosak, C., Wetzel, H., Hasslacher, C., Martin, T., Stein, J., Erdmann, E., Bohm, M., Hartmann, D., Breidert, M., Fritzen, R., Scherbaum, W., Mann, J., Maus, J., Schroeder, C., Henrichs, H., Unger, H., Ickenstein, G., Kromer, E., Riegger, G., Schunkert, H., Basan, B., Hampel, R., Crean, P., Garadah, T., White, U., Marini, N., Paciaroni, E., Saccomano, G., Diluzio, S., Magnani, B., Mantovani, B., Pareschi, P., Stucchi, N., Nanni, D., Rusticali, F., Simoni, C., Brunelli, C., Caponnetto, S., Gatto, E., Mazzantini, A., Molinari, O., Morello, R., Degiorgio, L., Imparato, C., Barbaresi, F., Cotogni, A., Pasqualini, M., Frigeni, G., Landoni, M., Polese, A., Cernigoi, A., Merni, M., Tortul, C., Velussi, M., Aina, F., Cernigliaro, C., Dellavesa, P., Dejoannon, U., Pierfranceschi, G., Zavaroni, D., Emilia, R., Manicardi, E., Minelli, E., Penazzoli, F., Portioli, I., Rossi, E., Giani, P., Roccaforte, R., Casaccia, M., Larovere, R., Miglierina, E., Repetto, S., Centofante, P., Vincenzi, M., Nieuwenhuijzen, Ac, Sels, J., Wolffenbuttel, Bhr, Kip, J., Mantingh, L., Mulder, H., Vandoorn, Lg, Hjerkinn, E., Reikvam, A., Cardona, M., Sanz, G., Karoni, A., Bescos, Ll, Albert, X., Masia, R., Alvarez, A., Saenz, L., Astrom, L., Press, R., Sjostedt, P., Tabrizi, F., Bergbom, I., Hansson, P., Held, C., Kahan, T., Ryden, B., Andersson, O., Wysocki, M., Karlsson, E., Sartor, G., Smith, L., Katzman, P., Ljungdahl, L., Noren, P., Hallberg, A., Olsson, Po, Asbrink, S., Molgaard, J., Nilsson, V., Nystrom, F., Ohman, P., Andersson, C., Ekholm, L., Svensson, Ka, Torebo, E., Fagher, B., Svenstam, I., Thulin, T., Ericsson, Ub, Ahnberg, K., Henning, R., Jacobsson, L., Taghavi, A., Ahlstrom, P., Rosenqvist, U., Ericson, C., Gertow, O., Kristensson, Be, Stahl, L., Bergsten, L., Harden, R., Jagren, C., Leijd, B., Lennerhagen, P., Ostergrens, J., Sandstrom, V., Sundelin, R., Hagg, A., Morlin, C., Pettersson, F., Wanders, A., Bjorkman, H., Karlsson, G., Larsson, H., Lonndahl, Y., Weber, P., Cozzi, R., Gerber, P., Moccetti, T., Safwan, E., Sessa, F., Binder, T., Boman, P., Kiowski, W., Lehman, R., Lull, B., Spinas, G., Jamieson, A., Kennedy, Ja, Kesson, C., Gryczka, R., Parker, P., Sidiki, S., Small, M., Struthers, S., Manns, J., Smithurst, H., Begg, A., Fisher, Bm, Bedford, C., Heller, S., Marlow, S., Munoz, Ec, Garcia, Hh, Ruiz, Ro, Meaney, E., Flores, Mi, Brown, E., Perry, G., Patel, G., Sarma, R., Szlachcic, Y., Dorman, J., Singh, B., Bailey, G., Clegg, L., Horwitz, L., Leahy, J., Rashkow, A., Hudson, M., Miller, A., Umberger, J., Zoble, R., Orander, P., Sridharan, M., Defrancisco, G., Davidson, M., Islam, N., Mathew, J., Rajanahally, R., French, D., Wickemeyer, W., Effron, M., Goldstein, M., Utley, K., Pierpont, G., Weigenant, J., Farkouh, M., Kubly, V., Rich, M., Wisneski, L., Abrams, J., Garcia, D., Bonora, M., Kohn, R., Muffoletto, E., Brink, D., Lader, E., Singler, A., Pande, P., Powers, J., Hoogwerf, B., Moore, J., Yanak, F., Gupta, S., Williams, D., Danisa, K., Kirk, C., Wescott, B., Grover, J., Mackenzie, M., Amidi, M., Bell, M., Farmer, J., Kingry, C., Young, J., Harms, V., Kennedy, Jw, Letterer, R., Heller, C., and Mack, R.
14. Optimization and Standardization of the Extraction Method of Balanites aegyptiaca Del. Seeds (Zygophyllaceae) Used in the Formulation of an Antiparasitic Phytomedicine.
- Author
-
Belemlilga MB, Ouedraogo S, Boly GAL, Dao DH, Coulibaly JT, Ouedraogo JCRP, Compaoré S, Traore S, Koala M, Youl ENH, Belemnaba L, Kini FB, Traore A, Kouanda S, and Ouedraogo S
- Abstract
Background/Objectives: Balanites aegyptiaca Del. (Zygophyllaceae) is widely used in traditional medicine, both human and veterinary, throughout Africa for its many properties, including antiparasitic properties. This experimental study aims to optimize the extraction conditions of the seeds of Balanites aegyptiaca Del. Methods: Aqueous maceration was carried out with mass-to-volume ratios of 40%, 30%, 20%, 10% and 5% and extraction times of 6, 12, 24, 36 and 48 h. Extraction yields, phytochemical screening, saponins assay, antioxidant activities ABTS+ free radical scavenging activities, Ferric-reducing antioxidant power (FRAP) assay and antiparasitic tests on Heligmosomoides bakeri were used to compare the different extracts. Results: The pharmaco-chemical study generally showed that aqueous maceration gave the best results, with a mass/volume ratio of 10% after 12 h of maceration. The yield obtained was 28.03% with a saponins content of 13.81 mg/g. The antioxidant activities were 4.25 ± 0.17 µg/mL by the ABTS method and 0.739 µg/mL by the FRAP method. The larvicidal activity also showed that the 10% 12 h extract produced 100% larval mortality from 25 µg/mL. Conclusions: These data provide a basis for guiding the extraction process parameters in producing this antiparasitic phytomedicine.
- Published
- 2024
- Full Text
- View/download PDF
15. Atezolizumab-Associated Retiform Purpura.
- Author
-
Sidiki S, Fatima R, Hernández NC, and Altorok N
- Subjects
- Aged, Humans, Lung Neoplasms drug therapy, Antibodies, Monoclonal, Humanized adverse effects, Purpura chemically induced
- Abstract
Competing Interests: The authors have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
16. Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural Mali.
- Author
-
Doucoure M, Zeguime A, Niangaly A, Guindo MA, Doritchamou JYA, Assadou MH, Katile A, Kanoute MB, Perou S, Ouattara A, Sanogo S, Ouologuem B, Traore S, Dao B, Dembele D, Kone M, Kamate B, Sissoko K, Sankare S, Diarra S, Dolo A, Sissoko MS, Hume JCC, Cook D, Healy SA, Gorres JP, Traoré B, Gamiel J, Duffy PE, and Sagara I
- Subjects
- Humans, Mali epidemiology, Male, Female, Adolescent, Adult, Child, Child, Preschool, Reference Values, Middle Aged, Infant, Young Adult, Aged, Aged, 80 and over, Age Factors, Sex Factors, Hemoglobins analysis, Creatinine blood, Laboratories, Clinical, Blood Cell Count, Rural Population statistics & numerical data
- Abstract
The interpretation of a laboratory test result requires an appropriate reference range established in healthy subjects, and normal ranges may vary by factors such as geographic region, sex, and age. We examined hematological and clinical chemistry parameters in healthy residents at two rural vaccine trial sites: Bancoumana and Doneguebougou in Mali, West Africa. During screening of clinical studies in 2018 and 2019, peripheral blood samples from 1,192 apparently healthy individuals age 6 months to 82 years were analyzed at a laboratory accredited by the College of American Pathologists for a complete blood count, and creatinine and/or alanine aminotransferase levels. Based on manufacturers' reference range values, which are currently used in Malian clinical laboratories, abnormal values were common in this healthy population. In fact, 30.4% of adult participants had abnormal neutrophil levels and 19.8% had abnormal hemoglobin levels. Differences by sex were observed in those who were older, but not in those younger than 10 years, for several parameters, including hemoglobin, platelet, and absolute neutrophil counts in hematology, and creatinine in biochemistry. The site-specific reference intervals we report can be used in malaria vaccine clinical trials and other interventional studies, as well as in routine clinical care, to identify abnormalities in hematological and biochemical parameters among healthy Malian trial participants.
- Published
- 2024
- Full Text
- View/download PDF
17. Molnupiravir for the Treatment of Coronavirus Disease 2019: A Systematic Review With Meta-Analysis of 12,451 Patients.
- Author
-
Beran A, Mhanna A, Mhanna M, Farrow D, Sidiki S, Khader Y, Srour O, and Kayyali A
- Subjects
- Humans, Cytidine analogs & derivatives, Cytidine therapeutic use, Hydroxylamines therapeutic use, COVID-19, Antiviral Agents, COVID-19 Drug Treatment
- Abstract
Competing Interests: The authors have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
18. Long-Term Outcomes of Ahmed Glaucoma Valve Surgery in a Scottish Cohort of Patients With Refractory Glaucoma.
- Author
-
Siempis T, Younus O, Makuloluwa A, Montgomery D, Croghan C, and Sidiki S
- Abstract
Purpose The purpose of this study was to evaluate the long-term efficacy and safety profile of the Ahmed glaucoma valve (AGV) implantation in cases of refractory glaucoma. Methods We conducted a retrospective audit of patients that underwent AGV implantation between 2006 and 2017 by two glaucoma surgeons in a tertiary glaucoma centre (Glasgow, UK). Primary outcome measures included the post-operative intraocular pressure (IOP), number of glaucoma medications, best-corrected visual acuity, complications, re-operation rates, and failure (defined as IOP > 21 mmHg or not reduced by 20% from baseline, IOP ≤ 5 mmHg, reoperation for glaucoma, removal of implant, or loss of light perception) at pre-defined time points (years 1 to 8). Results A total of 111 eyes of 94 patients were identified with a mean follow-up of 48.5 months (SD: 31.5); 60.3% of eyes had undergone at least one previous glaucoma surgery. Mean presenting IOP was 31.7 mmHg (SD: 11.4), and it reduced to 13.9 mmHg (SD: 4.2) in year 5 and 16.3 mmHg in year 8 (p<0.05). The number of glaucoma medications reduced from 3.8 (SD: 1.4) to 2.4 (SD: 1.4) and 2.6 (SD: 1.4) in the above time points (p<0.05 except year 8). The five-year success rate was 65.2%, and the five-year reoperation rate was 37% excluding cataract surgery. The most common early complications were hyphaema (12.6%) and transient hypotony (8.1%), whereas the most common late complication was an encapsulated bleb (15.1%). Conclusions AGV implantation is an effective procedure for controlling IOP in the long term in cases of refractory glaucoma., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Siempis et al.)
- Published
- 2023
- Full Text
- View/download PDF
19. Correction to: Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala.
- Author
-
García JI, Meléndez J, Álvarez R, Mejía-Chew C, Kelley HV, Sidiki S, Castillo A, Mazariegos C, López-Téllez C, Forno D, Ayala N, Balada-Llasat JM, Mejía-Villatoro CR, Wang SH, Torrelles JB, and Ikeda J
- Published
- 2022
- Full Text
- View/download PDF
20. Immunoglobulin A Vasculitis Associated With COVID-19 Infection Successfully Treated With Corticosteroid Regimen Without Relapse.
- Author
-
Davis S, Chandra A, Sidiki S, Abugharbyeh A, and Altorok N
- Abstract
Immunoglobulin A (IgA) vasculitis is an autoimmune disease associated with bacterial and viral infections that typically presents with palpable purpura, arthralgia, abdominal pain, and renal involvement. Coronavirus disease 2019 (COVID-19) infection has been found to trigger numerous autoimmune and rheumatologic conditions, including IgA vasculitis. We report a patient who had a COVID-19 infection and then two weeks later developed severe abdominal pain, nausea, emesis, diarrhea, hematochezia, palpable purpura, and arthralgia. Skin biopsy revealed deposition of IgA and C3 complement granular deposition with fibrinogen deposition in superficial dermal vessel walls consistent with IgA vasculitis. The patient was treated with intravenous methylprednisolone followed by oral prednisone with significant improvement and no relapse after tapering and discontinuing steroids in six weeks. This case of biopsy-proven IgA vasculitis precipitated by active COVID-19 infection demonstrates the ability of COVID-19 infection to induce IgA vasculitis and its response to corticosteroid treatment., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2022, Davis et al.)
- Published
- 2022
- Full Text
- View/download PDF
21. Anticonvulsant effects of Cymbopogon giganteus extracts with possible effects on fully kindled seizures and anxiety in experimental rodent model of mesio-temporal epilepsy induced by pilocarpine.
- Author
-
Pale S, Neteydji S, Taiwe GS, Kouemou Emegam N, and Bum EN
- Subjects
- Animals, Anti-Anxiety Agents administration & dosage, Anti-Anxiety Agents isolation & purification, Anti-Anxiety Agents pharmacology, Anticonvulsants administration & dosage, Anticonvulsants isolation & purification, Anxiety drug therapy, Disease Models, Animal, Dose-Response Relationship, Drug, Kindling, Neurologic drug effects, Male, Maze Learning drug effects, Pilocarpine, Plant Extracts administration & dosage, Rats, Rats, Wistar, Valproic Acid pharmacology, Anticonvulsants pharmacology, Cymbopogon chemistry, Epilepsy, Temporal Lobe drug therapy, Plant Extracts pharmacology
- Abstract
Ethnopharmacological Relevance: Epilepsy is a neurological disorder of the brain characterized by periodic and unpredictable occurrence of a transient behavior alteration due to the rhythmic, synchronous and disordered firing of brain neuron. Worldwide, approximately 50 million people currently live with epilepsy and close to 80% of people with epilepsy live in poor countries. However, it was noticed in many countries worldwide that people with epilepsy and their families suffer from stigma and discrimination and that situation exposes them to high psychological conditions such as depression and anxiety as well as more physical problems including bruising and fractures from injuries related to seizures. However, several plants-based products used for epilepsy and anxiety treatments in different system of folk medicine have exhibited a significant anti-epileptic and antianxiety activities using animal models with fewer side effects., Aim of the Study: The study aimed at evaluating the antiepileptic, status post-epilepticus and anxiolytic effects of Cymbopogon giganteus decoction in rat model induced by pilocarpine., Materials and Methods: A total of 90 rats were partitioned into 7 groups and treated as follow: animals of groups I (normal control) and II (considered the negative control) received distilled water (10 mL/kg); while groups III, IV, V, and VI were treated with the C. giganteus extract at 34, 85, 170 and 340 mg/kg p.o, respectively; and the group VII (considered positive control) received sodium valproate at 300 mg/kg, i.p. After 40 min post-treatment, a single dose of n-methyl-scopolamine (1 mg/kg, i.p) was administered to animals of groups (II, III, IV, V, VI, VII) followed by pilocarpine (360 mg/kg, i.p). Animal of group I (normal group) received distilled water. Rats were further observed for 6 h to evaluate the severity and the duration of the acute seizures of epilepsy according to Racine scale. Anxious behavior status post-epilepticus was also assessed in the same rats used above in the Elevated Plus Maze and number of entries into the open or closed arms and the time spent on either open or closed arms of the platform were recorded. Animals were also evaluated on Open Field Test and the number of rearing, crossing, grooming, defecation and center time were registered., Results: C. giganteus decoction significantly (P < 0.05) reduced the animal mortality, the number and duration of convulsions and effectively increased the latency of convulsions. The plant extract significantly (P < 0.05) improved GSH level and SOD activity, reduced MDA and CAT activity, increased GABA level and decreased GABA-t activity in hippocampus. The anxiety induced by pilocarpine was also significantly (P < 0.05) inhibited by the extract of the plant., Conclusions: Thus, C. giganteus has demonstrated its antiepileptic and anxiolytic activities in rat model and may be used as preventive measure for patients suffering from epilepsy seizures and anxiety., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
22. Population Structure and Relatedness for Genome-Wide Association Studies.
- Author
-
Malle S
- Subjects
- Polymorphism, Single Nucleotide, Software, Genetic Association Studies, Genetics, Population, Glycine max genetics
- Abstract
The estimation of the population structure and genetic relatedness between individuals within a collection of accessions is important in the formation of core collections for the conservation of genetic resources, uncovering the demographic history of the population under study, as well as for association studies. With the recent development of high-throughput genotyping technologies, several algorithms and methods have been developed and implemented in software to estimate the extent of genetic diversity between individuals. In this chapter, our objective is to describe methods to capture population structure and relatedness in a step-by-step fashion. To exemplify the process, two pruned datasets (14K and 243K SNP markers) were used to investigate population structure and relatedness among a soybean GWAS panel using different approaches and methods., (© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
23. A Practical Guide to Using Structural Variants for Genome-Wide Association Studies.
- Author
-
Lemay MA and Malle S
- Subjects
- Genotype, Phenotype, Genome-Wide Association Study methods
- Abstract
Structural variants (SVs) are known to have large functional impacts on phenotypes of agricultural interest, but they have yet to be routinely used for GWAS. Apart from the difficulty in obtaining high-quality SV genotype data for large populations, one of the main hurdles to using SVs for GWAS lies in formatting of genotype data for use with popular GWAS programs. This protocol describes how typical SV genotype data can be formatted for input to three GWAS programs commonly used by the plant genetics community: TASSEL, GAPIT, and mrMLM., (© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
24. Concordance of vaccination status and associated factors with incomplete vaccination: a household survey in the health district of Segou, Mali, 2019.
- Author
-
Sangaré S, Sangho O, Doumbia L, Marker H, Sarro YDS, Dolo H, Telly N, Zakour IB, Ndiaye HM, Sanogo M, Sangho F, Diarra NH, Sangho A, Traoré FB, Diallo B, Coulibaly CA, Ongoiba S, Diakité L, and Doumbia S
- Subjects
- Child, Cross-Sectional Studies, Female, Humans, Infant, Mali, Prospective Studies, Immunization Programs, Vaccination
- Abstract
Introduction: the region of Segou recorded 36.8% of children were incompletely vaccinated in 2018. In 2019, the district of Segou was one of the districts with the lowest vaccination coverage in the region, with 85.1% coverage for the three doses of the pentavalent vaccine and 85.4% for the measles vaccine. This study was initiated to better understand this low vaccination coverage, in the absence of specific studies on vaccination coverage in the district of Segou., Methods: a prospective cross-sectional study was conducted from May to August 2020 with 30 clusters. We performed Kappa coefficient, bivariate, and multiple logistic regression analysis., Results: findings showed that 18.46% (101/547) [15.44-21.93] of children were incompletely vaccinated. Mothers correctly reported the vaccination status of their children in 67.30% of cases (Kappa coefficient). Uneducated (OR[IC95%]=2.13[1.30-3.50]), living in rural area (OR[IC95%]=2.07[1.23-3.47]), lack of knowledge of Expanded Program on Immunization (EPI) target diseases (OR[IC95%]=2.37[1.52-3.68]), lack of knowledge of vaccination schedule (OR[IC95%]=3.33[1.90-5.81]) and lack of knowledge of the importance of vaccination (OR[IC95%]=3.6[2.35-6.32]) were associated with incomplete vaccination. In multivariate analysis, uneducated (ORa[IC95%>]=1.68[1.004-2.810]) and lack of knowledge of the importance of vaccination were associated with incomplete vaccination (ORa[IC95%]=3.40[2.049-5.649])., Conclusion: findings showed a good concordance of the vaccination status. Living in a rural area, no education, lack of the knowledge of EPI target diseases, lack of the knowledge of vaccination schedule and lack of knowledge of the importance of vaccination were associated with incomplete vaccination., Competing Interests: The authors declare no competing interests., (Copyright: Sidiki Sangaré et al.)
- Published
- 2021
- Full Text
- View/download PDF
25. [Epidemiological profile of COVID-19 in Tombouctou region in Mali].
- Author
-
Sangho O, Balam A, Togola OB, Sankaré MH, Kassogué D, Dara C, Sanogo S, Doumbia Z, Diarra I, Diarra L, Ballo A, Guindo S, Sangho A, Ballayira Y, Dembélé A, Coulibaly CA, and Sangho F
- Abstract
Introduction: The objective of our study was to establish the epidemiological profile of COVID-19 in Tombouctou., Material and Methods: This was a descriptive cross-sectional study of COVID-19 surveillance data from Tombouctou from April 3 to October 1, 2020. Our variables of interest were extracted from the surveillance database and analyzed with Excel 2013. The frequencies, rate, and ratio were computed., Results: Overall, 1851 suspects from all districts of the region were screened by RT-PCR, including 572 confirmed, which indicate a positivity rate of 30.90%. The 15-34 age group was the most represented with 48% of the confirmed cases. The sex ratio (male / female) of confirmed cases was 2.67. The city of Tombouctou was the epicenter of COVID-19. The Tombouctou region had a detection rate of around 2‰ (1851/928,000) and peaked between weeks 22 and 23 with a case fatality of 2.8%., Conclusion: Young people and men were most likely to be infected with COVID-19. We recommend increasing awareness of compliance with barrier measures., (Le comité de rédaction se réserve le droit de renvoyer aux auteurs avant toute soumission à l'avis des lecteurs les manuscrits qui ne seraient pas conformes à ces modalités de présentation. En outre il leur conseille de conserver un exemplaire du manuscrit, des figures et des tableaux.)
- Published
- 2021
26. Genome-wide association identifies several QTLs controlling cysteine and methionine content in soybean seed including some promising candidate genes.
- Author
-
Malle S, Eskandari M, Morrison M, and Belzile F
- Subjects
- Cysteine metabolism, Genome-Wide Association Study, Methionine metabolism, Seeds genetics, Glycine max metabolism, Cysteine genetics, Genome, Plant, Methionine genetics, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Seeds metabolism, Glycine max genetics
- Abstract
Soybean is an important source of protein, oil and carbohydrates, as well as other beneficial nutrients. A major function of proteins in nutrition is to supply adequate amounts of amino acids. Although they are essential for human nutrition, the sulfur-containing amino acids cysteine (Cys) and methionine (Met) are often limited and the genetic control of their content in soybean seeds is poorly characterized. This study aimed to characterize the phenotypic variation and identify quantitative trait loci (QTL) associated with Cys and Met content in a core set of 137 soybean lines, representative of the genetic diversity among Canadian short-season soybean, spanning maturity groups 000-II (MG000-II). Significant phenotypic differences were found among these lines for Cys, Met and Cys + Met content. Using both a mixed linear model and six multi-locus methods with a catalogue of 2.18 M SNPs, we report a total of nine QTLs and seventeen QTNs of which seven comprise promising candidate genes. This work allowed us to reproducibly detect multiple novel loci associated with sulfur-containing amino acid content. The markers and genes identified in this study may be useful for soybean genetic improvement aiming to increase Cys and Met content.
- Published
- 2020
- Full Text
- View/download PDF
27. Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala.
- Author
-
García JI, Meléndez J, Álvarez R, Mejía-Chew C, Kelley HV, Sidiki S, Castillo A, Mazariegos C, López-Téllez C, Forno D, Ayala N, Balada-Llasat JM, Mejía-Villatoro CR, Wang SH, Torrelles JB, and Ikeda J
- Subjects
- Diagnostic Tests, Routine, Guatemala epidemiology, Humans, Lipopolysaccharides, Longitudinal Studies, Point-of-Care Systems, Prospective Studies, Sensitivity and Specificity, HIV Infections diagnosis, HIV Infections drug therapy, HIV Infections epidemiology, Tuberculosis diagnosis, Tuberculosis epidemiology
- Abstract
Background: Improved point-of-care diagnostic tests for tuberculosis (TB) in severe immune suppressed people living with HIV (PLWH) are needed to decrease morbidity and mortality outcomes. The aim of the study is to evaluate the performance of the lipoarabinomannan antigen test (LAM-test) with and without α-mannosidase pre-treated urine in a cohort of PLWH in primary care clinics in Guatemala. We further determined TB incidence, and mortality rates and its risk factors in PLWH with TB symptoms., Methods: Prospective longitudinal study of PLWH with TB symptoms. Urine samples were collected at 2 HIV sites to test the sensitivity of the LAM-test in urine with and without α-mannosidase pre-treatment. A composite reference standard of either a positive Mycobacterium tuberculosis complex culture and/or GeneXpert
® MTB/RIF (Xpert, Cepheid, Sunnyvale, CA, USA) results was used in the LAM-test diagnostic accuracy studies. Cox proportional hazards regression was used to study mortality predictors., Results: The overall sensitivity of the LAM-test was of 56.1% with 95% CI of (43.3-68.3). There were no differences in the LAM-test sensitivity neither by hospital nor by CD4 T cell values. LAM-test sensitivity in PLWH with < 200 CD4 T cells/µl was of 62.2% (95% CI 46.5-76.2). There were no significant differences in sensitivity when comparing LAM-test results obtained from untreated vs. α-mannosidase treated urine [55.2% (95% CI 42.6-67.4) vs. 56.9% (95% CI 44-69.2), respectively]. TB incidence in our cohort was of 21.4/100 person years (PYs) (95% CI 16.6-27.6), and mortality rate was of 11.1/100 PYs (95% CI 8.2-15.0). Importantly, PLWH with a positive LAM-test result had an adjusted hazard ratio (aHR) of death of 1.98 (1.0-3.8) with a significant p value of 0.044 when compared to PLWH with a negative LAM-test result., Conclusions: In this study, α-mannosidase treatment of urine did not significantly increase the LAM-test performance, however; this needs to be further evaluated in a large-scale study due to our study limitations. Importantly, high rates of TB incidence and mortality were found, and a positive LAM-test result predicted mortality in PLWH with TB clinical symptoms.- Published
- 2020
- Full Text
- View/download PDF
28. Identification of loci controlling mineral element concentration in soybean seeds.
- Author
-
Malle S, Morrison M, and Belzile F
- Subjects
- Canada, Crops, Agricultural chemistry, Crops, Agricultural genetics, Plant Breeding, Reproducibility of Results, Gene Expression Regulation, Plant, Minerals analysis, Quantitative Trait Loci, Seeds chemistry, Seeds genetics, Glycine max chemistry, Glycine max genetics
- Abstract
Background: Mineral nutrients play a crucial role in the biochemical and physiological functions of biological systems. The enhancement of seed mineral content via genetic improvement is considered as the most promising and cost-effective approach compared alternative means for meeting the dietary needs. The overall objective of this study was to perform a GWAS of mineral content (Ca, K, P and S) in seeds of a core set of 137 soybean lines that are representative of the diversity of early maturing soybeans cultivated in Canada (maturity groups 000-II)., Results: This panel of 137 soybean lines was grown in five environments (in total) and the seed mineral content was measured using a portable x-ray fluorescence (XRF) spectrometer. The association analyses were carried out using three statistical models and a set of 2.2 million SNPs obtained from a combined dataset of genotyping-by-sequencing and whole-genome sequencing. Eight QTLs significantly associated with the Ca, K, P and S content were identified by at least two of the three statistical models used (in two environments) contributing each from 17 to 31% of the phenotypic variation. A strong reproducibility of the effect of seven out these eight QTLs was observed in three other environments. In total, three candidate genes were identified involved in transport and assimilation of these mineral elements., Conclusions: There have been very few GWAS studies to identify QTLs associated with the mineral element content of soybean seeds. In addition to being new, the QTLs identified in this study and candidate genes will be useful for the genetic improvement of soybean nutritional quality through marker-assisted selection. Moreover, this study also provides details on the range of phenotypic variation encountered within the Canadian soybean germplasm.
- Published
- 2020
- Full Text
- View/download PDF
29. Effect of Ar Gas Pressure on LSPR Property of Au Nanoparticles: Comparison of Experimental and Theoretical Studies.
- Author
-
Gezgin SY, Kepceoğlu A, Gündoğdu Y, Zongo S, Zawadzka A, Kiliç HŞ, and Sahraoui B
- Abstract
In this study, the thin films were produced by using pulsed laser deposition (PLD) technique from gold (Au) nanoparticles deposited on two kinds of substrates under different argon (Ar) gas pressure. Microscope glass slides and silicon (100) wafers were used as amorphous and crystal substrates. The films were deposited under 2 × 10
-3 mbar, 1 × 10-2 mbar, 2 × 10-2 mbar argon (Ar) ambient gas pressure. Effect of the background gas pressure on the plasma plume of the ablated Au nanoparticles was investigated in details. Morphology of Au nanoparticle thin films was investigated by means of atomic force microscopy (AFM) technique. Absorption spectra of Au nanoparticles were examined by using UV-Vis spectrometry. Extinction spectra of Au nanoparticles were calculated by using metallic nano particles boundary element method (MNPBEM) simulation programme. Both experimental spectra and simulation data for Au nanoparticles were obtained and compared in this work. It was concluded that they are also in good agreement with literature data. The measurements and the simulation results showed that localized surface plasmon resonance (LSPR) peaks for Au nanoparticles were located in the near infrared region (NIR) because of the larger size of the disk-like shape of Au nanoparticles, and the near-field coupling between Au nanoparticles. It was demonstrated that as the ambient gas (Ar) pressure was increased, the size and the density of Au nanoparticles on the substrate were decreased and the LSPR peak shifts toward the short wavelength region in the spectrum. This shift has been explained by the changes in the morphology of produced thin films.- Published
- 2020
- Full Text
- View/download PDF
30. Accuracy of Two Point-of-Care Tests for Rapid Diagnosis of Bovine Tuberculosis at Animal Level using Non-Invasive Specimens.
- Author
-
Kelley HV, Waibel SM, Sidiki S, Tomatis-Souverbielle C, Scordo JM, Hunt WG, Barr N, Smith R, Silwani SN, Averill JJ, Baer S, Hengesbach J, Yildiz VO, Pan X, Gebreyes WA, Balada-Llasat JM, Wang SH, and Torrelles JB
- Subjects
- Animals, Antigens urine, Cattle, Female, Humans, Lipopolysaccharides immunology, Male, Milk, Sensitivity and Specificity, Diagnostic Tests, Routine methods, Diagnostic Tests, Routine veterinary, Point-of-Care Testing, Specimen Handling methods, Specimen Handling veterinary, Tuberculosis, Bovine diagnosis
- Abstract
Bovine tuberculosis (BTB) testing in cattle requires a significant investment of time, equipment, and labor. Novel, rapid, cheaper and accurate methods are needed. The Alere Determine TB lipoarabinomannan antigen (LAM-test) is a World Health Organization-endorsed point-of-care urine test designed to detect active TB disease in humans. The Lionex Animal TB Rapid Test (Lionex-test) is a novel animal specific TB diagnostic blood test. An animal level analysis was performed using urine (n = 141) and milk (n = 63) samples from depopulated BTB-suspected cattle to test the accuracy of the LAM-test when compared to results of positive TB detection by any routine BTB tests (BOVIGAM, necropsy, histology, culture, PCR) that are regularly performed by the United States Department of Agriculture (USDA). The agreement between the urine LAM-test and USDA standard tests were poor at varying testing time points. The same milk samples did not elicit statistically significant agreement with the Lionex-test, although positive trends were present. Hence, we cannot recommend the LAM-test as a valid BTB diagnostic test in cattle using either urine or milk. The Lionex-test's production of positive trends using milk samples suggests larger sample sizes may validate the Lionex-test in accurately diagnosing BTB in cattle using milk samples, potentially providing a quick and reliable field test for BTB.
- Published
- 2020
- Full Text
- View/download PDF
31. Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human and Bovine Tuberculosis by Manipulating Urine and Milk.
- Author
-
García JI, Kelley HV, Meléndez J, de León RAA, Castillo A, Sidiki S, Yusoof KA, Nunes E, Téllez CL, Mejía-Villatoro CR, Ikeda J, García-Basteiro AL, Wang SH, and Torrelles JB
- Subjects
- Animals, Antigens, Bacterial immunology, Cattle, Female, Humans, Lipopolysaccharides immunology, Milk microbiology, Mycobacterium bovis immunology, Mycobacterium bovis isolation & purification, Mycobacterium tuberculosis immunology, Mycobacterium tuberculosis isolation & purification, Sensitivity and Specificity, Tuberculosis immunology, Tuberculosis microbiology, Tuberculosis urine, Tuberculosis, Bovine immunology, Tuberculosis, Bovine microbiology, Urine microbiology, Antigens, Bacterial isolation & purification, Immunologic Tests methods, Lipopolysaccharides isolation & purification, Point-of-Care Systems, Tuberculosis diagnosis, Tuberculosis, Bovine diagnosis
- Abstract
Tuberculosis (TB) disease still kills 1-person every 21-seconds. Few TB diagnostic tests are considered truly appropriate for point of care settings. The WHO-endorsed immunodiagnostic Alere Determine Lipoarabinomannan Ag-test (LAM-test) detects Mycobacterium tuberculosis complex LAM in urine, and its use is recommended for TB diagnosis among HIV co-infected individuals with low CD4 T-cell counts. Here we found that a simple 15-minute enzymatic treatment at room temperature of LAM-spiked urine with α-mannosidase (for human TB), and LAM-spiked milk with combined lactase and caseinase (for bovine TB), enhanced 10-fold the detection levels of the LAM-test and thus, improved the detection of LAM by the LAM-test in urine and milk that otherwise could be missed in the field. Future separate clinical research studies specifically designed to address the potential of these findings are required.
- Published
- 2019
- Full Text
- View/download PDF
32. Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
- Author
-
Mekonnen B, Mihret A, Getahun M, Hailu T, Sidiki S, V Kelley H, Scordo JM, Hunt WG, Pan X, Balada-Llasat JM, Gebreyes W, Evans CA, Aseffa A, Torrelles JB, Wang SH, and Abebe T
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antitubercular Agents pharmacology, Child, Color, Ethiopia, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis growth & development, Time Factors, Young Adult, Culture Techniques, Drug Resistance, Bacterial, Health Resources supply & distribution, Microbial Sensitivity Tests economics, Microbial Sensitivity Tests methods, Mycobacterium tuberculosis drug effects
- Abstract
Timely diagnosis of tuberculosis (TB) is limited in Ethiopia. We evaluated the performance of a low technology, thin layer agar, Mycobacterium tuberculosis (M.tb) culture color plate (TB-CX) test with concurrent drug susceptibility testing (DST) to isoniazid (INH), rifampin (RIF), and pyrazinamide (PZA) directly from sputum specimens. Patients undergoing examination for TB and multidrug-resistant (MDR)-TB were enrolled in Addis Ababa, Ethiopia from March 2016 to February 2017. All subjects received a GeneXpert MTB/RIF PCR test. TB-CX test results were compared to reference Löwenstein-Jensen (LJ) culture for M.tb detection and DST for susceptibility to INH and RIF. Kappa statistic was applied to test agreement between results for TB-CX test and the reference methods, a cut-off Kappa value of 0.75 was considered as high level of agreements. A total of 137 participants were analyzed: 88 (64%) were new TB cases, 49 (36%) were re-treatment cases. The TB-CX test detected M.tb and DST in an average of 13 days compared to 50 days for the conventional DST result. The sensitivity and specificity of the TB-CX test for detecting M.tb were 94% and 98%, respectively (concordance, 96%; kappa 0.91). The sensitivity of the TB-CX test to detect drug resistance to INH, RIF, and MDR-TB was 91%, 100%, and 90% respectively. The specificity of the TB-CX test for detecting INH, RIF, and MDR-TB was 94%, 40%, and 94% respectively. Overall agreement between TB-CX test and LJ DST for detection of MDR-TB was 93%. The TB-CX test showed strong agreement with the GeneXpert test for detecting M.tb (89%, kappa 0.76) but low agreement for the detection of RIF resistance (57%, kappa 0.28). The TB-CX test was found to be a good alternative method for screening of TB and selective drug resistant-TB in a timely and cost-efficient manner., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
33. Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosis.
- Author
-
Moliva JI, Hossfeld AP, Sidiki S, Canan CH, Dwivedi V, Beamer G, Turner J, and Torrelles JB
- Subjects
- Alkanes chemistry, Animals, BCG Vaccine chemistry, Female, Inflammation Mediators chemistry, Interleukin-17 metabolism, Lipid Metabolism, Lipids chemistry, Lung microbiology, Mice, Mice, Inbred C57BL, Vaccination, BCG Vaccine immunology, Inflammation Mediators immunology, Lipids immunology, Lung immunology, Mycobacterium bovis physiology, Mycobacterium tuberculosis physiology, Tuberculosis, Pulmonary immunology
- Abstract
Mycobacterium tuberculosis (M.tb), the causative agent of tuberculosis (TB), is the leading killer due to an infectious organism. Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the only vaccine approved against TB, however, its efficacy against pulmonary TB is poor. While BCG is currently inoculated intradermally, the natural route of M.tb infection is through the lung. Excessive lung pathology caused by pulmonary inoculation of BCG has prevented the use of this immunization route. Here, we show that selective chemical treatment of BCG with petroleum ether removes inflammatory lipids from the bacterial surface while keeping BCG viable. Pulmonary vaccination using this modified BCG attenuated inflammatory responses, prevented immunopathology of the lung, and significantly increased protection against M.tb infection in mice. We further directly linked IL-17A as the responsible contributor of improved immunity against M.tb infection. These results provide evidence that selective removal of cytotoxic lipids from the BCG surface attenuates inflammation and offers a safer and superior vaccine against TB causing less damage post-infectious challenge with M.tb.
- Published
- 2019
- Full Text
- View/download PDF
34. Late mortality after cardiac interventions over 10-year period in two Cameroonian government-owned hospitals.
- Author
-
Ngatchou W, Kamdem F, Lemogoum D, Ewane DF, Doualla MS, Jansens JL, Sango J, Origer P, Hacquebard JJ, Berre J, de Cannière D, Alima MB, Dzudie A, Ngote H, Mouliom S, Hentchoua R, Kana A, Coulibaly A, Jingi AM, Mfeukeu-Kuaté L, Priso EB, Luma H, Ménanga AP, and Kingue S
- Abstract
Background: Cardiac surgery is a growing activity in Sub-Saharan Africa, however, data related to long-term mortality are scarce. We aimed to analyze outcome data of cardiac interventions in two hospitals in Cameroon over 10 years' period., Methods: we conducted a retrospective analytical and descriptive study at the Douala General Hospital and Yaoundé General Hospital. All patients operated between January 2007 and December 2017, or their families were contacted by phone between January and April 2018 for a free of charges medical examination., Results: Of a total of 98 patients operated during the study period, 8 (8.2%) were lost to follow-up. Finally, 90 patients [49 (54.4%) women and 41 (45.6%)] men were included. The mean age was 49±22 years (range, 13-89 years). The surgical indications were valvular heart diseases in 37 (41.1%) cases, congenital heart diseases in 11 (12.2%) cases, chronic constrictive pericarditis in 4 (4.4%) cases, and intra cardiac tumor in 1 (1.1%) case. Valve replacement was the most common type of surgery carried out in 37 (41.1%) cases-mostly with mechanical prosthesis. Pacemaker-mostly dual-chambers were implanted in 36 (40.0%) patients. The median follow-up was 26 months. The overall late mortality was 5.7%, and the overall survival rates at 5 and 10 years were 95.5% and 94.4% respectively. The overall survival rates at 5 and 10 years for mechanical valve prosthesis were 93.3% and 90% respectively. The survival at 10 years was 100% for patients with bioprosthesis. The survival rates at 10 years were 94.1% and 100% respectively for dual and single chamber pacemaker., Conclusions: Long-term outcome of cardiac surgery in hospitals in Cameroon are acceptable with low mortality rate. However, outcome metrics beyond mortality should be implemented for a prospective data collection., Competing Interests: Conflicts of Interest: The authors have no conflicts of interest to declare.
- Published
- 2019
- Full Text
- View/download PDF
35. A Study of the Use and Outcomes From Respiratory Viral Testing at a Mid-Sized Children's Hospital.
- Author
-
Zhu C, Sidiki S, Grider B, Fink B, Hubbard N, and Mukundan D
- Subjects
- Adolescent, Child, Child, Preschool, Female, Humans, Infant, Inpatients statistics & numerical data, Length of Stay statistics & numerical data, Male, Retrospective Studies, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Emergency Service, Hospital, Hospitals, Pediatric, Respiratory Tract Infections diagnosis, Respiratory Tract Infections drug therapy
- Abstract
This study was a retrospective analysis of inpatient and emergency department (ED) data on respiratory pathogen panel (RPP) testing between December 16, 2013, and December 15, 2015, at a mid-sized children's hospital. We assessed whether RPP decreases antibiotic days of therapy and length of hospital stay for pediatric patients with acute respiratory infections. In the inpatient population, patients testing positive with RPP were given fewer antibiotic days of therapy (2.99 vs 4.30 days; P = .032) and had shorter hospital stays (2.84 vs 3.80 days; P = .055) than patients testing negative. In the ED population, patients testing positive with RPP received fewer discharge prescriptions for antibiotics than patients not tested (8.8% vs 41.1%; P < .001). RPP use was more prevalent in admitted patients than in ED patients (78.9% vs 7.3%; P < .001). Our results suggest that RPP testing curbs antibiotic use and decreases length of hospital stay.
- Published
- 2019
- Full Text
- View/download PDF
36. [Platelet collection in cardiac surgery: first experience with apheresis at the General Hospital in Douala].
- Author
-
Ngatchou W, Dreezen I, Kamdem F, Imandy G, Okalla C, Nkana A, Hacquebard JP, Origer P, Sango J, Lemogoum D, Mouliom S, Dzudie A, Ngote H, Hentchoya R, Metogo J, Germay O, Priso EB, Jansens JL, Luma H, and Najdovski T
- Subjects
- Adult, Blood Loss, Surgical prevention & control, Blood Preservation methods, Cameroon, Hospitals, General, Humans, Male, Blood Component Removal methods, Blood Platelets, Cardiac Surgical Procedures methods, Extracorporeal Circulation methods
- Abstract
Cardiac surgery with extracorporeal circulation (ECC) is usually associated with the loss of a significant amount of blood. Adequate prophylaxis against blood loss and good perioperative hemostasis are known as processes limiting postoperative bleeding. Until now, the need for platelets in patients operated with extracorporeal circulation in our Department has been compensated for by total blood transfusion or platelet concentrates collected from several donors. We here report our first experience with platelet concentrate collection by apheresis at the General Hospital in Douala., Competing Interests: Les auteurs ne déclarent aucun conflit d'intérêts.
- Published
- 2018
- Full Text
- View/download PDF
37. Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi.
- Author
-
Zhang A, Jumbe E, Krysiak R, Sidiki S, Kelley HV, Chemey EK, Kamba C, Mwapasa V, García JI, Norris A, Pan XJ, Evans C, Wang SH, Kwiek JJ, and Torrelles JB
- Abstract
Background: Rural settings where molecular tuberculosis diagnostics are not currently available need easy-to-use tests that do not require additional processing or equipment. While acid-fast bacilli (AFB) smear is the most common and often only tuberculosis diagnosis test performed in rural settings, it is labour intensive, has less-than-ideal sensitivity, and cannot assess tuberculosis drug susceptibility patterns., Objective: The objective of this study was to determine the feasibility of a multidrug-resistant (MDR) or extensively drug-resistant (XDR)-tuberculosis coloured agar-based culture test (tuberculosis CX-test), which can detect Mycobacterium tuberculosis growth and evaluate for drug susceptibility to isoniazid, rifampicin and a fluoroquinolone (i.e. ciprofloxacin) in approximately 14 days., Method: In this study, 101 participants were enrolled who presented to a rural health clinic in central Malawi. They were suspected of having active pulmonary tuberculosis. Participants provided demographic and clinical data and submitted sputum samples for tuberculosis testing using the AFB smear and tuberculosis CX-test., Results: The results showed a high level of concordance between the AFB smear (12 positive) and tuberculosis CX-test (13 positive); only one sample presented discordant results, with the molecular GeneXpert MTB/RIF
® test confirming the tuberculosis CX-test results. The average time to a positive tuberculosis CX-test was 10 days. Of the positive samples, the tuberculosis CX-test detected no cases of drug resistance, which was later confirmed by the GeneXpert MTB/RIF® ., Conclusion: These findings demonstrate that the tuberculosis CX-test could be a reliable low-cost diagnostic method for active pulmonary tuberculosis in high tuberculosis burden rural areas., Competing Interests: The authors declare that they have no financial or personal relationships which may have inappropriately influenced them in writing this article.- Published
- 2018
- Full Text
- View/download PDF
38. Clinical, echocardiographic, and therapeutic aspects of congenital heart diseases of children at Douala General Hospital: A cross-sectional study in sub-Saharan Africa.
- Author
-
Kamdem F, Kedy Koum D, Hamadou B, Yemdji M, Luma H, Doualla MS, Noukeu D, Barla E, Akazong C, Dzudie A, Ngote H, Monkam Y, Mouliom S, and Kingue S
- Subjects
- Adolescent, Cameroon epidemiology, Child, Child, Preschool, Cross-Sectional Studies, Female, Follow-Up Studies, Heart Defects, Congenital epidemiology, Heart Defects, Congenital surgery, Humans, Infant, Infant, Newborn, Male, Morbidity trends, Socioeconomic Factors, Survival Rate trends, Cardiac Surgical Procedures statistics & numerical data, Disease Management, Echocardiography methods, Forecasting, Heart Defects, Congenital diagnosis, Hospitals, General statistics & numerical data
- Abstract
Introduction: Cardiovascular diseases in pediatric pathologies have emerged in the recent years in sub-Saharan Africa (SSA), with congenital heart diseases (CHDs) being the most frequent. Unfortunately, their diagnosis is usually delayed, thereby increasing childhood morbidity and mortality., Objectives: Describe the clinical, echocardiographic, and therapeutic aspects of CHDs of children at Douala General Hospital., Methods: We carried out a cross-sectional descriptive study over a 10-year period, from January 2006 to December 2015. Files and reports of cardiac ultrasounds of patients aged ≤ 15 years were reviewed., Results: We reviewed the medical records of 1616 children, of which 370 (22.9%) had CHD. The age range was 1 day to 15 years, with a mean of 26 months. Heart murmur was the most frequent clinical sign, seen in 72.3% of the cases. CHD with left-to-right shunt was seen in 61.8%, with ventricular septal defect being the most common (29.8% of all cases). The second most common CHDs were those due to obstruction (20.4%), mainly pulmonary stenosis (19.6% of all cases). Cyanogenic CHDs accounted for 17.8% of cases, dominated by tetralogy of Fallot (7.4% of all cases). Indications for surgical treatment was found in 171 (46.2%) patients, but due to financial constraints, only 48 (28.1%) patients were operated. Among those who underwent surgery, 66.7% were operated abroad, and Humanitarian organizations financed the surgical management of 58.3% of those operated., Conclusions: CHDs are seen in one out of five children seen in the pediatric cardiology unit of our Hospital for suspected heart disease. Most cases are diagnosed late in life as toddlers. The rate of surgical correction remains low due to financial constraints, with most cases operated abroad with the assistance of Humanitarian organizations., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
39. Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
- Author
-
Boisen ML, Cross RW, Hartnett JN, Goba A, Momoh M, Fullah M, Gbakie M, Safa S, Fonnie M, Baimba F, Koroma VJ, Geisbert JB, McCormick S, Nelson DK, Millett MM, Oottamasathien D, Jones AB, Pham H, Brown BL, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Pitts KR, Geisbert TW, Branco LM, Khan SH, Grant DS, and Garry RF
- Subjects
- Ebolavirus genetics, Ebolavirus isolation & purification, Hemorrhagic Fever, Ebola epidemiology, Hemorrhagic Fever, Ebola virology, Hospitals, Humans, RNA, Viral blood, Reagent Kits, Diagnostic, Real-Time Polymerase Chain Reaction, Reproducibility of Results, Sensitivity and Specificity, Sierra Leone, Antigens, Viral blood, Ebolavirus immunology, Hemorrhagic Fever, Ebola diagnosis, Immunoassay methods, Point-of-Care Systems
- Abstract
Background: The 2013-2016 West African Ebola virus disease (EVD) epidemic is the largest recorded. Triage on the basis of clinical signs had limited success, and the time to diagnosis by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) could exceed 5 days. Here we describe the development and field validation of the ReEBOV Antigen Rapid Test (ReEBOV RDT) to aid triage of individuals with suspected EVD., Methods: Samples from patients with suspected EVD were submitted to Kenema Government Hospital, Sierra Leone, for Lassa fever and EVD screening throughout 2014. Banked residual clinical samples were tested in November 2014 and January 2015 in a blinded field trial to estimate the clinical effectiveness of the ReEBOV RDT, compared with EBOV-specific qRT-PCR., Results: Preliminary ReEBOV RDT performance demonstrated a positive percentage agreement (PPA) of 91.1% (195 of 214 results; 95% confidence interval [CI], 86.5%-94.6%) and a negative percentage agreement (NPA) of 90.2% (175 of 194; 95% CI, 85.1%-94.0%). The final estimates used by the Food and Drug Administration to determine whether to grant emergency use authorization for the test, which excluded a qRT-PCR reference method threshold cutoff, were a PPA of 62.1% (72 of 116 results; 95% CI, 52.6%-70.9%) and a NPA of 96.7% (58 of 60; 95% CI, 88.5%-99.6%), with a diagnostic likelihood of 18.6. A subsequent, independent evaluation by the World Health Organization generated results consistent with the preliminary performance estimates., Conclusions: The ReEBOV RDT demonstrated the potential to provide clinically effective rapid and accurate point-of-care test results and, thus, to be a powerful tool for increasing triage efficiency., (© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
40. ANXIOLYTIC - LIKE PROPERTIES OF Hallea ciliata IN MICE.
- Author
-
Stephanie NKJ, Gisele NN, Clarisse MOF, Germain TS, Neteydji S, Simon P, Rigobert AME, and Elisabeth NB
- Subjects
- Animals, Anti-Anxiety Agents chemistry, Anxiety psychology, Behavior, Animal drug effects, Female, Humans, Male, Mice, Plant Extracts chemistry, Anti-Anxiety Agents administration & dosage, Anxiety drug therapy, Plant Bark chemistry, Plant Extracts administration & dosage, Rubiaceae chemistry
- Abstract
Background: The aim of the present study was to evaluate the anxiolytic properties of the decoction of stem bark of Hallea ciliate in mice. The decoction of Hallea ciliata is used in traditional medicine in Cameroon to treat diseases like anxiety disorders, fever, infantile convulsions and malaria., Materials and Methods: Stress induced hyperthermia, elevated plus maze, open field and hole-board tests were used. Four different doses of the decoction were administered to mice and their effects were compared to the effects of diazepam and vehicle. Phytochemical characterization of the decoction revealed the presence of alkaloids, flavonoids, tannins and saponins., Results: Administration of Hallea ciliata resulted in a significant decrease of stress induced hyperthermia in mice at the doses of 29.5, 59 and 118 mg/kg. In the elevated plus maze test, Hallea ciliata increased the number of entries and the percentages of entries and time into the open arms, and reduced the number of entries and the percentages of entries and time into the closed arms. In the hole-board test, Hallea ciliata increased the number of both head-dipping and crossing and decreased the latency to the first head-dips and rearing. The decoction of Hallea ciliata and diazepam increased locomotion in the open field test., Conclusion: The number of rearing and the mass of fecal boli produced were decreased in mice treated with decoction and diazepam. In conclusion, the results indicated that decoction of Hallea ciliata has anxiolytic-like properties in mice and could potentially be used for anxiety treatment.
- Published
- 2016
- Full Text
- View/download PDF
41. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.
- Author
-
Andersen KG, Shapiro BJ, Matranga CB, Sealfon R, Lin AE, Moses LM, Folarin OA, Goba A, Odia I, Ehiane PE, Momoh M, England EM, Winnicki S, Branco LM, Gire SK, Phelan E, Tariyal R, Tewhey R, Omoniwa O, Fullah M, Fonnie R, Fonnie M, Kanneh L, Jalloh S, Gbakie M, Saffa S, Karbo K, Gladden AD, Qu J, Stremlau M, Nekoui M, Finucane HK, Tabrizi S, Vitti JJ, Birren B, Fitzgerald M, McCowan C, Ireland A, Berlin AM, Bochicchio J, Tazon-Vega B, Lennon NJ, Ryan EM, Bjornson Z, Milner DA Jr, Lukens AK, Broodie N, Rowland M, Heinrich M, Akdag M, Schieffelin JS, Levy D, Akpan H, Bausch DG, Rubins K, McCormick JB, Lander ES, Günther S, Hensley L, Okogbenin S, Schaffner SF, Okokhere PO, Khan SH, Grant DS, Akpede GO, Asogun DA, Gnirke A, Levin JZ, Happi CT, Garry RF, and Sabeti PC
- Subjects
- Africa, Western epidemiology, Animals, Biological Evolution, Disease Reservoirs, Ebolavirus genetics, Genetic Variation, Glycoproteins genetics, Hemorrhagic Fever, Ebola virology, Humans, Lassa Fever epidemiology, Lassa Fever transmission, Lassa virus classification, Lassa virus physiology, Murinae genetics, Mutation, Nigeria epidemiology, Viral Proteins genetics, Zoonoses epidemiology, Zoonoses virology, Genome, Viral, Lassa Fever virology, Lassa virus genetics, RNA, Viral genetics
- Abstract
The 2013-2015 West African epidemic of Ebola virus disease (EVD) reminds us of how little is known about biosafety level 4 viruses. Like Ebola virus, Lassa virus (LASV) can cause hemorrhagic fever with high case fatality rates. We generated a genomic catalog of almost 200 LASV sequences from clinical and rodent reservoir samples. We show that whereas the 2013-2015 EVD epidemic is fueled by human-to-human transmissions, LASV infections mainly result from reservoir-to-human infections. We elucidated the spread of LASV across West Africa and show that this migration was accompanied by changes in LASV genome abundance, fatality rates, codon adaptation, and translational efficiency. By investigating intrahost evolution, we found that mutations accumulate in epitopes of viral surface proteins, suggesting selection for immune escape. This catalog will serve as a foundation for the development of vaccines and diagnostics. VIDEO ABSTRACT., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
42. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak.
- Author
-
Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, Hastie KM, Hartnett JN, Momoh M, Fullah M, Gabiki M, Safa S, Zandonatti M, Fusco M, Bornholdt Z, Abelson D, Gire SK, Andersen KG, Tariyal R, Stremlau M, Cross RW, Geisbert JB, Pitts KR, Geisbert TW, Kulakoski P, Wilson RB, Henderson L, Sabeti PC, Grant DS, Garry RF, Saphire EO, Branco LM, and Khan SH
- Subjects
- Antibodies, Bacterial blood, Antibodies, Viral blood, DNA, Protozoan blood, Enzyme-Linked Immunosorbent Assay, Hemorrhagic Fevers, Viral pathology, Humans, Immunoglobulin G blood, Immunoglobulin M blood, Polymerase Chain Reaction, RNA, Viral blood, Retrospective Studies, Seroepidemiologic Studies, Sierra Leone epidemiology, Disease Outbreaks, Hemorrhagic Fevers, Viral epidemiology, Hemorrhagic Fevers, Viral etiology
- Abstract
Lassa fever (LF) is a severe viral hemorrhagic fever caused by Lassa virus (LASV). The LF program at the Kenema Government Hospital (KGH) in Eastern Sierra Leone currently provides diagnostic services and clinical care for more than 500 suspected LF cases per year. Nearly two-thirds of suspected LF patients presenting to the LF Ward test negative for either LASV antigen or anti-LASV immunoglobulin M (IgM), and therefore are considered to have a non-Lassa febrile illness (NLFI). The NLFI patients in this study were generally severely ill, which accounts for their high case fatality rate of 36%. The current studies were aimed at determining possible causes of severe febrile illnesses in non-LF cases presenting to the KGH, including possible involvement of filoviruses. A seroprevalence survey employing commercial enzyme-linked immunosorbent assay tests revealed significant IgM and IgG reactivity against dengue virus, chikungunya virus, West Nile virus (WNV), Leptospira, and typhus. A polymerase chain reaction-based survey using sera from subjects with acute LF, evidence of prior LASV exposure, or NLFI revealed widespread infection with Plasmodium falciparum malaria in febrile patients. WNV RNA was detected in a subset of patients, and a 419 nt amplicon specific to filoviral L segment RNA was detected at low levels in a single patient. However, 22% of the patients presenting at the KGH between 2011 and 2014 who were included in this survey registered anti-Ebola virus (EBOV) IgG or IgM, suggesting prior exposure to this agent. The 2014 Ebola virus disease (EVD) outbreak is already the deadliest and most widely dispersed outbreak of its kind on record. Serological evidence reported here for possible human exposure to filoviruses in Sierra Leone prior to the current EVD outbreak supports genetic analysis that EBOV may have been present in West Africa for some time prior to the 2014 outbreak.
- Published
- 2015
- Full Text
- View/download PDF
43. Clinical illness and outcomes in patients with Ebola in Sierra Leone.
- Author
-
Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schaffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Massally JL, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi C, Gevao SM, Fletcher TE, Fowler RA, Bausch DG, Sabeti PC, Khan SH, and Garry RF
- Subjects
- Abdominal Pain, Adult, Animals, Diarrhea, Ebolavirus isolation & purification, Female, Fever, Hemorrhagic Fever, Ebola complications, Hemorrhagic Fever, Ebola therapy, Hemorrhagic Fever, Ebola virology, Humans, Male, Middle Aged, Mortality, Reverse Transcriptase Polymerase Chain Reaction, Sierra Leone epidemiology, Viral Load, Vomiting, Ebolavirus genetics, Epidemics, Hemorrhagic Fever, Ebola epidemiology
- Abstract
Background: Limited clinical and laboratory data are available on patients with Ebola virus disease (EVD). The Kenema Government Hospital in Sierra Leone, which had an existing infrastructure for research regarding viral hemorrhagic fever, has received and cared for patients with EVD since the beginning of the outbreak in Sierra Leone in May 2014., Methods: We reviewed available epidemiologic, clinical, and laboratory records of patients in whom EVD was diagnosed between May 25 and June 18, 2014. We used quantitative reverse-transcriptase-polymerase-chain-reaction assays to assess the load of Ebola virus (EBOV, Zaire species) in a subgroup of patients., Results: Of 106 patients in whom EVD was diagnosed, 87 had a known outcome, and 44 had detailed clinical information available. The incubation period was estimated to be 6 to 12 days, and the case fatality rate was 74%. Common findings at presentation included fever (in 89% of the patients), headache (in 80%), weakness (in 66%), dizziness (in 60%), diarrhea (in 51%), abdominal pain (in 40%), and vomiting (in 34%). Clinical and laboratory factors at presentation that were associated with a fatal outcome included fever, weakness, dizziness, diarrhea, and elevated levels of blood urea nitrogen, aspartate aminotransferase, and creatinine. Exploratory analyses indicated that patients under the age of 21 years had a lower case fatality rate than those over the age of 45 years (57% vs. 94%, P=0.03), and patients presenting with fewer than 100,000 EBOV copies per milliliter had a lower case fatality rate than those with 10 million EBOV copies per milliliter or more (33% vs. 94%, P=0.003). Bleeding occurred in only 1 patient., Conclusions: The incubation period and case fatality rate among patients with EVD in Sierra Leone are similar to those observed elsewhere in the 2014 outbreak and in previous outbreaks. Although bleeding was an infrequent finding, diarrhea and other gastrointestinal manifestations were common. (Funded by the National Institutes of Health and others.).
- Published
- 2014
- Full Text
- View/download PDF
44. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak.
- Author
-
Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, and Sabeti PC
- Subjects
- Base Sequence, Ebolavirus isolation & purification, Genetic Variation, Genome, Viral genetics, Genomics methods, Hemorrhagic Fever, Ebola epidemiology, Humans, Mutation, Sequence Analysis, DNA, Sierra Leone epidemiology, Disease Outbreaks, Ebolavirus genetics, Epidemiological Monitoring, Hemorrhagic Fever, Ebola transmission, Hemorrhagic Fever, Ebola virology
- Abstract
In its largest outbreak, Ebola virus disease is spreading through Guinea, Liberia, Sierra Leone, and Nigeria. We sequenced 99 Ebola virus genomes from 78 patients in Sierra Leone to ~2000× coverage. We observed a rapid accumulation of interhost and intrahost genetic variation, allowing us to characterize patterns of viral transmission over the initial weeks of the epidemic. This West African variant likely diverged from central African lineages around 2004, crossed from Guinea to Sierra Leone in May 2014, and has exhibited sustained human-to-human transmission subsequently, with no evidence of additional zoonotic sources. Because many of the mutations alter protein sequences and other biologically meaningful targets, they should be monitored for impact on diagnostics, vaccines, and therapies critical to outbreak response., (Copyright © 2014, American Association for the Advancement of Science.)
- Published
- 2014
- Full Text
- View/download PDF
45. Molecular composition of the alveolar lining fluid in the aging lung.
- Author
-
Moliva JI, Rajaram MV, Sidiki S, Sasindran SJ, Guirado E, Pan XJ, Wang SH, Ross P Jr, Lafuse WP, Schlesinger LS, Turner J, and Torrelles JB
- Subjects
- Adult, Animals, Female, Humans, Hydrolases metabolism, Male, Mice, Aging metabolism, Lung metabolism, Oxidative Stress, Pulmonary Alveoli metabolism, Pulmonary Surfactant-Associated Protein A metabolism
- Abstract
As we age, there is an increased risk for the development of pulmonary diseases, including infections, but few studies have considered changes in lung surfactant and components of the innate immune system as contributing factors to the increased susceptibility of the elderly to succumb to infections. We and others have demonstrated that human alveolar lining fluid (ALF) components, such as surfactant protein (SP)-A, SP-D, complement protein C3, and alveolar hydrolases, play a significant innate immune role in controlling microbial infections. However, there is a lack of information regarding the effect of increasing age on the level and function of ALF components in the lung. Here we addressed this gap in knowledge by determining the levels of ALF components in the aging lung that are important in controlling infection. Our findings demonstrate that pro-inflammatory cytokines, surfactant proteins and lipids, and complement components are significantly altered in the aged lung in both mice and humans. Further, we show that the aging lung is a relatively oxidized environment. Our study provides new information on how the pulmonary environment in old age can potentially modify mucosal immune responses, thereby impacting pulmonary infections and other pulmonary diseases in the elderly population.
- Published
- 2014
- Full Text
- View/download PDF
46. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
- Author
-
Coulibaly SO, Kayentao K, Taylor S, Guirou EA, Khairallah C, Guindo N, Djimde M, Bationo R, Soulama A, Dabira E, Barry B, Niangaly M, Diakite H, Konate S, Keita M, Traore B, Meshnick SR, Magnussen P, Doumbo OK, and ter Kuile FO
- Subjects
- Adolescent, Adult, Asymptomatic Infections epidemiology, Asymptomatic Infections therapy, Biomarkers blood, Burkina Faso epidemiology, Dried Blood Spot Testing, Drug Combinations, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Malaria epidemiology, Mali epidemiology, Parasite Load, Polymerase Chain Reaction, Pregnancy, Young Adult, Antimalarials therapeutic use, Drug Resistance, Malaria drug therapy, Pyrimethamine therapeutic use, Sulfadoxine therapeutic use
- Abstract
Background: Intermittent Preventive Treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) is widely used for the control of malaria in pregnancy in Africa. The emergence of resistance to SP is a concern requiring monitoring the effectiveness of SP for IPTp., Methods: This was an in-vivo efficacy study to determine the parasitological treatment response and the duration of post-treatment prophylaxis among asymptomatic pregnant women receiving SP as part of IPTp in Mali and Burkina-Faso. The primary outcome was the PCR-unadjusted % of patients with parasites recurrence by day 42 defined as a positive diagnostic test by malaria smear at any visit between days 4 and 42. Treatment failure was based on the standard World Health Organization criteria. The therapeutic response was estimated using the Kaplan-Meier curve., Results: A total of 580 women were enrolled in Mali (N=268) and Burkina-Faso (N=312) and followed weekly for 42 days. Among these, 94.3% completed the follow-up. The PCR-unadjusted cumulative risk of recurrence by day 42 was 4.9% overall, and 3.2% and 6.5% in Mali and Burkina Faso respectively (Hazard Ratio [HR] =2.14, 95%, CI [0.93-4.90]; P=0.070), and higher among the primi- and secundigravida (6.4%) than multigravida (2.2%, HR=3.01 [1.04-8.69]; P=0.042). The PCR-adjusted failure risk was 1.1% overall (Mali 0.8%, Burkina-Faso 1.4%). The frequencies (95% CI) of the dhfr double and triple mutant and dhps 437 and 540 alleles mutant genotype at enrolment were 24.2% (23.7-25.0), 4.7% (4.4-5.0), and 21.4% (20.8-22.0) and 0.37% (0.29-0.44) in Mali, and 7.1% (6.5-7.7), 44.9% (43.8-46.0) and 75.3% (74.5-76.2) and 0% in Burkina-Faso, respectively. There were no dhfr 164L or dhps 581G mutations., Conclusion: SP remains effective at clearing existing infections when provided as IPTp to asymptomatic pregnant women in Mali and Burkina. Continued monitoring of IPTp-SP effectiveness, including of the impact on birth parameters in this region is essential.
- Published
- 2014
- Full Text
- View/download PDF
47. Systemic diclofenac sodium to maintain mydriasis during phacoemulsification.
- Author
-
Sidiki SS and Wykes WN
- Subjects
- Administration, Oral, Aged, Humans, Mydriatics administration & dosage, Ophthalmic Solutions, Prospective Studies, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Cyclooxygenase Inhibitors administration & dosage, Diclofenac administration & dosage, Phacoemulsification, Pupil drug effects
- Abstract
Purpose: To determine whether systemic diclofenac sodium affects the maintenance of mydriasis during phacoemulsification and to compare pupil diameter regression rates with those in a control group., Setting: An ophthalmic unit of a National Health Service Trust Hospital in the United Kingdom., Method: A prospective, randomized control study of 100 patients presenting for cataract surgery was undertaken. Both groups were administered an identical mydriatic regime commencing 1 hour before surgery. In addition, the diclofenac group (n = 48) received 50 mg of oral diclofenac sodium 1 hour before surgery. Both the control (n = 52) and diclofenac groups had phacoemulsification by one experienced surgeon using a standard technique. The surgeon was masked as to which group the patient belonged. The irrigating fluid in all cases contained adrenaline. Pupil diameter was measured at five stages during surgery and recorded along with the times relative to the start of the procedure., Results: Mean pupil diameter in the diclofenac group was slightly larger than in the control group, but the difference was not significant. Although mean pupil diameter at the start of surgery was 0.4 mm greater in the diclofenac group, the slopes of regression in pupil diameters were virtually identical between the first three stages of surgery, after which a slight reversal occurred in both groups. The slope of regression of mydriasis was small in both groups., Conclusion: Systemic diclofenac sodium 50 mg given orally 1 hour before surgery did not significantly inhibit miosis when compared with a control group. Regression rates of pupil mydriasis were small in both groups.
- Published
- 1998
- Full Text
- View/download PDF
48. Factors that influence patient choice of an excimer laser treatment center.
- Author
-
Orr D, Sidiki SS, and McGhee CN
- Subjects
- Adult, Aged, Female, Humans, Lasers, Excimer, Male, Middle Aged, National Health Programs, Refraction, Ocular, Surveys and Questionnaires, Visual Acuity, Choice Behavior, Cornea surgery, Myopia surgery, Patient Satisfaction, Photorefractive Keratectomy psychology
- Abstract
Purpose: To identify the factors that most influenced patient choice of an excimer laser treatment center and those most likely to deter patients from selecting a particular center., Setting: A National Health Service (NHS) excimer laser unit in the northeast of England., Methods: An anonymous 24-item questionnaire was constructed. Each question had a visual analogue scale, anchored at each end with an adjectival description. Patients were asked to mark their response to the related question on the scale. Using the database of over 300 patients treated by excimer laser photorefractive keratectomy (PRK) at Sunderland Eye infirmary between May 1993 and December 1995, the first 140 consecutive patients were identified. Questionnaires were sent to them and returned between August 1 and October 31, 1995., Results: A 64.3% reply rate (90 patients) was achieved. Overall, the results suggest that patients considered many factors to be important in their selection of a treatment center for PRK correction of myopia. Over 95% said that treatment and review by a consultant ophthalmologist, comprehensive follow-up appointments, professional attitude by staff, and reputation of the hospital were important factors in their selection of the center. Ninety to 95% said confidence in the clinical reputation and skills of the ophthalmic surgeons performing the treatment was important, as was having follow-up by only one or two staff members. Slightly more than 50% said that being treated in an NHS hospital setting (51.7%) or that expense of the treatment (50.5%) were important factors in their decision., Conclusion: Patients who chose to have excimer laser PRK based their choice of a unit on reputation of the staff and hospital but also on having care and follow-up by a consultant ophthalmic surgeon, high standards of equipment, continuity of care, and a comprehensive review system backed up by ready accessibility to staff members. Although proximity of a unit was important, cost appeared less important than the other factors.
- Published
- 1998
- Full Text
- View/download PDF
49. Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation.
- Author
-
Coupland SE, Sidiki S, Clark BJ, McClaren K, Kyle P, and Lee WR
- Subjects
- Aged, Antigens, Neoplasm analysis, Choroid Neoplasms chemistry, Choroid Neoplasms surgery, Follow-Up Studies, Humans, Immunoenzyme Techniques, Male, Melanoma chemistry, Melanoma surgery, Orbital Neoplasms chemistry, Tomography, X-Ray Computed, Choroid Neoplasms pathology, Eye Enucleation, Melanoma secondary, Orbital Neoplasms secondary
- Abstract
Metastatic uveal melanoma to the contralateral orbit is extremely rare, with only eight cases in the literature having been reported. We reviewed the clinical presentation, the histologic findings of the primary and secondary tumors, and the clinical outcome of these cases and studied an additional case of metastatic choroidal melanoma to the contralateral orbit that occurred 40 years after enucleation for the primary tumor. The long interval between recognition of the primary tumor and the appearance of clinically manifest metastatic disease in the contralateral orbit is the longest reported in the literature to date. The histologic features of the tumor cells of the enucleation specimen and those of the orbital metastasis were similar, consisting of spindle-cell type with minimal atypia. Combined use of immuno-phenotyping and electron microscopy substantiated the diagnosis of melanoma.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.